Printer Friendly
The Free Library
21,440,770 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Side effects may include overpayment.

Our first target should be prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug,  commercials. These were banned until a few years ago, but have rapidly proliferated. In 2003, Pfizer spent $87.6 million on marketing Celebrex Cel·e·brex

A trademark for the drug celecoxib.


celecoxib

Celebrex

Pharmacologic class: Nonsteroidal cyclooxygenase-2 (COX-2) inhibitor, nonsteroidal anti-inflammatory drug (NSAID)

, and Merck spent $79.2 million on Vioxx Vi·oxx

A trademark for the drug rofecoxib.


Vioxx® Rofecoxib Pain management A COX-2 inhibitor used to manage osteoarthritic pain, acute pain in adults, primary dysmenorrhea.
See COX-2 inhibitor.
. Since these drugs have been found to significantly increase the risk of heart disease, the harm they do is clear. A study published recently in the Archives of Internal Medicine The Archives of Internal Medicine is a bi-monthly international peer-reviewed professional medical journal published by the American Medical Association. Archives of Internal Medicine  shows that the good these drugs do could be effectively accomplished by much cheaper over-the-counter products in the case of at least 73 percent of patients.
COPYRIGHT 2005 Washington Monthly Company
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Tilting at Windmills; drug advertising
Author:Peters, Charles
Publication:Washington Monthly
Article Type:Brief Article
Geographic Code:1USA
Date:Mar 1, 2005
Words:94
Previous Article:I'm sorry, did you say anything?
Next Article:That's a lot of frooty pebbles.
Topics:



Related Articles
Mitigating agency problems by advertising, with special reference to managed health care.
N.J. court finds exception to learned intermediary doctrine.
Alberta drugists oppose drug-to-consumer advertising. (Health).
The pharmaceutical drive to drug. (Technology & Society).
A spoon full of sugar: what drug companies don't want you to know.
JOURNAL CITES AMGEN DRUG SENSIPAR TREATS DIALYSIS EFFECTS.
Side effects.
Dangerous practices: critics see flaws in drug-safety monitoring.
Chump change.
Now you can actually understand the disclaimer.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles